Obese adipose tissue (AT) inflammation contributes critically to development of insulin resistance. The complement anaphylatoxin C5a receptor (C5aR) has been implicated in inflammatory processes and as regulator of macrophage activation and polarization. However, the role of C5aR in obesity and AT inflammation has not been addressed. We engaged the model of diet-induced obesity and found that expression of C5aR was significantly upregulated in the obese AT, compared with lean AT. In addition, C5a was present in obese AT in the proximity of macrophage-rich crownlike structures. C5aR-sufficient and -deficient mice were fed a highfat diet (HFD) or a normal diet (ND). C5aR deficiency was associated with increased AT weight upon ND feeding in males, but not in females, and with increased adipocyte size upon ND and HFD conditions in males. However, obese C5aR 2/2 mice displayed improved systemic and AT insulin sensitivity. Improved AT insulin sensitivity in C5aR 2/2 mice was associated with reduced accumulation of total and proinflammatory M1 macrophages in the obese AT, increased expression of IL-10, and decreased AT fibrosis. In contrast, no difference in b cell mass was observed owing to C5aR deficiency under an HFD. These results suggest that C5aR contributes to macrophage accumulation and M1 polarization in the obese AT and thereby to AT dysfunction and development of AT insulin resistance.
O besity is associated with the development of insulin resistance, type 2 diabetes, and cardiovascular diseases (1) (2) (3) (4) (5) . Obesity is considered a state of chronic progressive low-grade inflammation. In particular, inflammation of the obese white adipose tissue (WAT) can directly contribute to the development of insulin resistance (1-3, 5, 6) . A hallmark of obese WAT inflammation is increased accumulation of inflammatory cells, including cytotoxic T cells and macrophages (1-3, 5, 6) . In the obese WAT, macrophages are skewed to the classically activated proinflammatory M1 macrophage phenotype (1) (2) (3) (5) (6) (7) (8) (9) . In contrast, macrophages constitutively present in the lean WAT are, rather, alternatively activated anti-inflammatory M2-polarized macrophages. The latter alternatively activated M2 subtype (10) (11) (12) secretes anti-inflammatory cytokines, such as IL-10, whereas classically activated M1-polarized macrophages that accumulate in the WAT with increasing obesity secrete proinflammatory cytokines that can directly interfere with insulin signaling, rendering the WAT insulin resistant (13, 14) .
A central component involved in the activation of innate immunity, inflammation, and tissue remodeling is the complement system. Cleavage of complement C3 into C3a and C3b is the point at which all three major complement activation pathways-the classical, alternative, and lectin pathways-merge (15, 16) . The further cleavage of C5 results in generation of the active anaphylatoxin C5a, which acts through its cellular G-protein-coupled receptor complement C5aR receptor (C5aR) (15) , and the membrane attack complex initiating fragment C5b. Of interest, adipocytes can secrete several complement factors, such as C3 or factor B and factor D, that serve as activating factors of the alternative complement pathway, implying a role of complement in adipose tissue (AT) biology (15, 17, 18) . In particular, factor D, also named adipsin, leads to the production of acylation-stimulating protein (ASP); this pathway has been reported to act as a regulator of lipid metabolism (19) . The absence of ASP, for example, in mice deficient in C3, resulted in reduced fat storage in adipocytes and delayed triglyceride and fatty acid clearance from circulation after a fat meal (20) . Furthermore, C3aR-deficient mice on a highfat diet displayed reduced weight gain associated with decreased macrophage infiltration in WAT and showed reduced insulin resistance (21) . In contrast to the aforementioned, the role of the C5a-C5aR axis in obesity and WAT inflammation has not been addressed so far. In this study, we engaged the model of dietinduced obesity (DIO) to elucidate the contribution of C5aR to obesity-associated WAT inflammation and insulin resistance. Our findings that C5aR-deficient mice displayed improved WAT insulin sensitivity and reduced WAT inflammation associated with decreased macrophage accumulation, reduced M1 macrophage polarization, and reduced fibrosis suggest that the C5a-C5aR axis contributes to WAT inflammation and insulin resistance.
Materials and Methods

Animal experiments
C5aR
2/2 mice were previously described (22, 23) . C57BL/6 mice were from Janvier (Saint Berthevin Cedex, France). Mice 6 to 8 wk old were fed a highfat diet (HFD) or a normal diet (ND) (60% kcal from fat or 10% kcal from fat, respectively; Research Diets, New Brunswick, NJ) for different time periods up to 28 wk. Body weight was recorded weekly. Animal experiments were approved by the Landesdirektion Dresden, Germany.
For i.p. glucose tolerance tests (GTTs), mice were starved overnight (24) (25) (26) (27) (28) or, alternatively, for 6 h with free access to drinking water. Glucose levels were measured at baseline via tail-vein blood sampling with an Accu-Chek glucose meter (Roche, Mannheim, Germany). Subsequently, mice were injected i.p. with 10% D-(+)-glucose (1 g/kg; Sigma-Aldrich, Munich, Germany), and glucose levels were monitored at indicated time points. For insulin tolerance tests (ITTs), mice were fasted for 5-6 h prior to i.p. injection of 0.75 U/kg insulin (Lilly, Bad Homburg, Germany) in male mice fed an ND and in female mice fed an HFD, or 1 U/kg insulin i.p. in male mice fed an HFD, and glucose levels were monitored at indicated time points. For serum insulin analysis, mice were starved for 6 h prior to blood collection, and insulin was measured using an insulin immunoassay (Chrystal Chem, Cologne, Germany). After euthanasia of mice, blood was collected, and the serum was analyzed using adiponectin and leptin immunoassays (R&D Systems, Wiesbaden-Nordenstadt, Germany).
Stromal vascular fraction isolation and FACS analysis
Previously described protocols were followed (3, 29) , with some modifications. Briefly, mice were euthanized, and subcutaneous white adipose tissue (sWAT) and gonadal WAT (gWAT) fat pads were isolated, minced, and digested with collagenase type I (2 mg/ml per milligram of tissue; Life Technologies, Darmstadt, Germany) for 45 min. The suspension was resuspended in DMEM containing 0.5% fatty acid-poor BSA (SigmaAldrich) and 1% penicillin/streptomycin, filtered through a 100-mm cell strainer (BD, Heidelberg, Germany), and centrifuged at 300 3 g for 5 min to separate the floating adipocyte fraction from the pelleted SV fraction. For FACS analysis, the stromal vascular fraction (SVF) was resuspended in HBSS (Invitrogen) with 0.1% fatty acid-poor BSA and 0.1% NaN 3 , filtered through a 40-mm cell strainer. For staining, the following Abs were used: Fc receptor-blocking Ab 2.4G2, CD11b-APC, CD11c-PE (BD); CD45-Alexa Fluor 488, CD11c-APC (BioLegend, Fell, Germany); CD31-APC, F4/80-Alexa Fluor 488 (eBioscience, Frankfurt, Germany); CD206/ MRC1-PE (Acris Abs, Herford, Germany); and CD8a-APC, CD4-FITC, CD3e-PE (Miltenyi Biotec, Bergisch Gladbach, Germany). Staining of CD206 was performed after overnight fixation of cells with a fixation/ permeabilization buffer (eBioscience, Frankfurt, Germany). FACS was carried out on a FACSCanto II (BD) and analyzed with FACSDiva Version 6.1.3 software. For triple staining for F4/80/CD11b/CD11c, events being double positive for F4/80-Alexa Fluor 488 and CD11b-APC were selected and regated for CD11c positivity. For triple staining for F4/80/CD11c/ CD206, events being positive for F4/80-Alexa Fluor 488 were selected and regated for being either positive for CD11c-APC, positive for CD206-PE or positive for both CD11c and CD206.
In vivo phospho-Akt signaling study
We followed previously published protocols (30, 31) . Briefly, mice on an HFD were fasted for 5 h prior to i.p. injection of 2 U/kg insulin (Lilly). After 8 min, mice were euthanized, and gWAT, sWAT, and liver tissues were harvested and shock frozen in liquid nitrogen. For protein isolation from WAT, 100 mg tissue was homogenized with an IKA T10 basic Ultra-Turrax Homogenizer in 1 ml 13 RIPA lysis buffer [1% Triton X-100; 0.5% sodium deoxycholate; 0.1% SDS; 50 mM Tris-HCL, pH 7.5; 150 mM NaCL; Mini Protease Inhibitor and Phosphatase Inhibitor Cocktail Tablet (Roche)] and centrifuged at 14,000 3 g for 15 min at 4˚C. The fatty layer was removed and the liquid phase transferred in a new tube. After incubation in an ultrasonic bath, the liquid phase was centrifuged two more times before measurement of its protein concentration using the BCA Protein Assay Kit (Thermo Scientific, Schwerte, Germany). For protein isolation from the liver, 50 mg tissue was homogenized in 1 ml 13 RIPA lysis buffer and centrifuged at 13,000 3 g for 15 min at 4˚C. The liquid phase was transferred in a new tube, and protein concentration was determined.
Equal amounts of protein/tissue (15 mg for sWAT and gWAT, 25 mg for liver) were loaded per lane on a 10% SDS-PAGE gel. Protein was transferred to a nitrocellulose membrane (GE Healthcare, Munich, Germany). The membrane was blocked with TBST containing 5% w/v skim milk (BD, Heidelberg, Germany), incubated overnight with the first Ab against phosphoAkt (phospho-Akt-Ser 473 ) (Cell Signaling/New England Biolabs, Frankfurt am Main, Germany), and then incubated with a goat anti-rabbit secondary Ab conjugated with HRP. The blot was developed with SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific), and the signal was detected with a luminescent image analyzer, LAS-3000 (Fujifilm, Dusseldorf, Germany). Membranes were stripped in a buffer containing 62.5 mM Tris-HCl (pH = 6.8), 2% SDS, and 100 mM 2-MΕ (all from Sigma-Aldrich) in a water bath at 50˚C for 20 min, blocked with TBST containing 5% w/v skim milk, and incubated with an Ab against total Akt (Cell Signaling) prior to development and signal detection as described above. Insulin-induced phospho-Akt was evaluated by normalization over total Akt signaling, using ImageJ software.
Immunohistochemistry
We followed previously described protocols (13, 32, 33) , with some modifications. Frozen WAT samples were fixed in 4% paraformaldehyde (PFA) at 4˚C overnight before embedding in paraffin. For each individual mouse, 4-mm sections were cut and mounted, and staining was performed with Mayer´s hematoxylin (SAV, Flintsbach am Inn, Germany) counterstained with 1% eosin (Pharmacy of the University Clinic Carl-Gustav-Carus, Dresden, Germany). For assessing fibrosis, Masson's trichrome staining was performed according to the manufacturer's instructions (Sigma-Aldrich). Other sections were mounted on silane-treated slides (Marienfeld, LaudaKönigshofen, Germany) and stained with anti-F4/80 Ab (Novus Biologicals, Herford, Germany). For this purpose, Ag retrieval was performed with citrate buffer (Sigma-Aldrich) followed by peroxidase (Dako Deutschland, Hamburg, Germany) and proteinase K blocking (Sigma-Aldrich). The avidin-biotin complex was detected with a AEC Peroxidase Substrate Kit (Vector Laboratories, Peterborough, U.K.). Finally, slides were stained with hematoxylin and mounted.
For determination of adipocyte size, pictures of H&E-stained sections were obtained at 3100 magnification. The diameter of ∼ 200 adipocytes per slide was measured with the AxioVision Rel. 4.8 software (Carl Zeiss MicroImaging, Jena, Germany). The diameters of both height and width were measured for each cell.
For histochemical staining of the liver with Oil Red O (ORO), 10-mm cryosections were prepared. Briefly, slides were fixed in ice-cold 10% formalin solution for 10 min, rinsed in dH 2 O, and stained for 15 min in ORO in 60% isopropanol solution (ORO:H 2 O, 3:2). They were rinsed in 60% isopropanol, and nuclei were counterstained with Mayer's hematoxylin. Slides were rinsed in H 2 O and mounted with 95% glycerol.
For C5a staining, frozen gWAT derived from mice fed an ND or HFD for 18 wk was fixed in 4% PFA at 4˚C overnight before embedding in paraffin and sectioning. Ag demasking was performed with citrate buffer. Sections were stained with a rabbit anti-C5a Ab in blocking buffer at 4˚overnight. This anti-C5a Ab was generated using KLH-conjugated synthetic peptide encompassing a sequence within the N-terminal region of human C5a (thus, detection of C5 is not excluded) and was purified by protein-G affinity chromatography (1:200; Abbiotec, San Diego, CA). Specificity of the anti-C5a Ab was tested by showing that the anti-C5a reactivity could be blocked by preincubation of the Ab with C5a. In the negative control, the first Ab was omitted. After washing with PBS, the sections were probed with an HRP-conjugated goat anti-rabbit Ab (1:250; Sigma-Aldrich) in blocking buffer for 1 h. For signal detection, we used the AEC Peroxidase Substrate Kit (Vector Laboratories) according to the instructions of the manufacturer. Sections were counterstained with hematoxylin. Coverslipped slides were examined using a microscope (Zeiss, Oberkochen, Germany).
Freshly isolated pancreata were fixed in 4% PFA at 4˚C for up to 4 d before embedding in paraffin. Sections were mounted on silane-treated slides (Marienfeld), and immunohistochemistry (IHC) staining was performed with an anti-insulin Ab and a secondary biotinylated goat anti-guinea pig Ab (Abcam, Cambridge, U.K.). Ag retrieval was performed with pepsin (Sigma-Aldrich). Endogenous biotin block, streptavidin-HRP, and color development were performed with a peroxidase VECTASTAIN ABC Kit and a AEC Peroxidase Substrate Kit (Vector Laboratories). Finally, slides were counterstained with Mayer's hematoxylin and mounted with a waterbased mounting medium. For determination of islet morphology, pictures were obtained as mosaics at 3100 magnification. The areas of pancreas and islets were measured with the AxioVision Rel. 4.8 software (Carl Zeiss MicroImaging), and b cell mass was calculated by multiplying the percentage of measured pancreatic area occupied by b cells by the total pancreatic weight (34).
Quantitative real-time PCR
RNA from AT and liver of C5aR-sufficient and -deficient mice was extracted with TRIzol (Invitrogen, Darmstadt, Germany). cDNA was synthesized with an iScript cDNA Synthesis Kit (Bio-Rad, Munich, Germany), and mRNA expression levels of each gene were quantified by quantitative real-time PCR using SsoFast EvaGreen Supermix (Bio-Rad) and a Bio-Rad cycler system (Bio-Rad) using gene-specific primers and normalization to 18S mRNA. Relative gene expression was calculated with the DDCt method (35) . The fold-change ratio was calculated and expressed as mean 6 SEM.
Statistical analysis
Data were analyzed with the independent Mann-Whitney U test.
Results
The presence of C5a and C5aR expression in obese AT
To determine the regulation of C5aR expression in the WAT, we analyzed C5aR mRNA in the gWAT obtained from mice that were fed an HFD. In particular, male WT mice were fed an ND or HFD for different time periods up to 26 wk. C5aR mRNA expression increased upon DIO already at 12 wk on an HFD, continuing to increase and reaching a peak at 18 wk on an HFD and remaining significantly elevated at 26 wk on an HFD, compared with respective ND-fed mice (Fig. 1A) . Thus, C5aR mRNA expression in the gWAT increased upon DIO in a time-dependent manner. Moreover, a significant upregulation of C5aR mRNA was observed in the sWAT of DIO mice (data not shown).
To analyze the presence of the C5aR ligand in the obese gWAT, we performed immunohistological studies for C5a at 18 wk on an HFD versus an ND, as this represented the time point with maximal C5aR upregulation in the gWAT. Of note, very little C5a was found in the gWAT of lean mice, whereas the presence of C5a in the gWAT of obese mice was substantial (Fig. 1B) . Interestingly, the majority of C5a staining was observed as diffuse staining within crownlike structures (CLS), which are usually macrophage rich (Fig. 1B) . These findings indicate that C5a and C5aR are elevated in the obese WAT and that activation of C5a and C5aR may correlate with WAT inflammation.
The role of C5aR in HFD-induced obesity
Next, C5aR-sufficient-and -deficient mice were fed a control ND or an HFD. Male C5aR 2/2 mice on ND displayed increased weight gain, compared with male wild-type (WT) mice; however, no weight difference was seen between WT and C5aR 2/2 mice upon feeding with an HFD (Fig. 1C, 1D ). Consistently, the total weights of lean sWAT and lean gWAT isolated from C5aR-deficient male mice were higher, as compared with male C5aR-sufficient lean sWAT and lean gWAT, respectively, whereas no significant difference in male sWAT and gWAT weights was observed upon HFD feeding between C5aR deficiency and C5aR sufficiency ( Fig. 2A, 2E) . Moreover, the adipocyte size of gWAT from C5aR-deficient male mice was increased, compared with that of C5aR-sufficient male mice under both ND and HFD feeding (Fig. 2B-D, 2F-H) , although there was no difference in adipocyte size from obese sWAT owing to C5aR deficiency (Supplemental Fig 1A, 1B) . The increased adipocyte size and AT weight of male mice caused by C5aR deficiency was apparently not due to altered lipogenesis in the AT, as the expression of lipogenesis genes, such as ACC (acetyl-CoA carboxylase), FAS (fatty acid synthase), SREBP-1c (sterol regulatory element-binding protein), or PPARg (peroxisome proliferator-activated receptor g), was unchanged ( Supplemental Fig. 1C) . Together, these findings suggest that in male mice C5aR deficiency is associated with increased adipocyte size of the gWAT.
However, we could not detect any C5aR deficiency-related difference in female mice with regard to weight gain upon feeding of an ND or HFD (Fig 1E, 1F) ; to total weight of sWAT and gWAT of lean and obese mice and to total weight of liver of obese mice ( Supplemental Fig. 1D) ; and to adipocyte size of sWAT and gWAT of obese and gWAT of lean mice (Supplemental Fig. 1E, 1G) . Thus, the increase in adipocyte size of the gWAT associated with C5aR deficiency was present only in males.
Next, we assessed the effect of C5aR deficiency on glucose tolerance and insulin sensitivity. C5aR-deficient male mice, upon feeding of an HFD, displayed a mild improvement in early insulin sensitivity after 19 wk of HFD feeding (Fig. 3A) . The improved insulin sensitivity of C5aR-deficient mice upon HFD feeding was accompanied by improved glucose tolerance at 18 wk of an HFD (Fig. 3B) . In addition to a GTT after overnight starvation (shown in Fig. 3B) , we also performed a GTT after a 6-h starvation period, which yielded similar results-that is, a mild but significant improvement in glucose tolerance in C5aR 2/2 mice compared with WT mice (data not shown). Data acquired in an experimental HFD feeding with female mice revealed a similar phenotype associated with C5aR deficiency-mildly improved insulin sensitivity (Fig. 3C ) and glucose tolerance (Fig. 3D) -thereby strengthening the conclusion that C5aR partially contributes to insulin resistance. In the course of an ITT performed after a 6-h starvation period, a reduction in basal glucose values in C5aR 2/2 mice, compared with WT mice, was observed (data not shown). Besides slightly higher fasting glucose values in the GTT, C5aR-deficient male mice, despite being overweight, displayed no difference in glucose tol- erance and insulin sensitivity under conditions of ND feeding, compared with C5aR-sufficient male mice (Supplemental Fig. 2A,  2B ). Furthermore, no difference in fasting insulin levels (Supplemental Fig. 2C ) or in leptin or adiponectin levels (data not shown) was observed upon HFD feeding, owing to C5aR deficiency.
To further verify and understand the partial contribution of C5aR to insulin resistance, we performed an in vivo insulin signaling assay. To this end, obese C5aR 2/2 or WT mice were fasted for 5 h prior to injection of insulin. Mice were euthanized 8 min after injection of insulin, and their gWAT, sWAT, and liver were collected and analyzed. We found that gWAT derived from C5aR
animals displayed a higher phosphorylated Akt/total Akt ratio, as assessed by Western blot analysis, thus indicating improved insulin sensitivity in C5aR deficiency (Fig. 4A, 4B ). In contrast, insulin sensitivity of the obese sWAT or the liver was not altered owing to C5aR deficiency (Supplemental Fig. 2D, 2E ). This finding is in accordance with the idea that, in obesity, visceral (gonadal) AT contributes more to insulin resistance than does subcutaneous AT. The weights of the C5aR-deficient and -sufficient mice engaged in insulin signaling experiments were not different (data not shown). These observations suggest that C5aR partially contributes to gWAT insulin resistance and not to resistance in other insulin target organs. Consistently, we could not detect any difference in liver steatosis (Supplemental Fig. 3A ) due to C5aR deficiency. Moreover, lipogenesis genes, such as ChREBP (carbohydrate-responsive element-binding protein), ACC, FAS, SREBP-1c, or PPARg (Supplemental Fig. 3B ), were indistinguishable between liver samples from C5aR-sufficient and -deficient mice.
Taken together, our findings suggest that, in DIO, C5aR partially contributes to insulin resistance via inhibition of insulin sensitivity of the gWAT.
Reduced AT inflammation and M1 macrophage polarization in C5aR-deficient mice upon HFD feeding
We then continued to explain the mild improvement in systemic and gWAT insulin sensitivity in obese C5aR-deficient mice. We have previously reported that the C5a-C5aR axis may promote macrophage polarization toward the proinflammatory M1 phenotype (23) . The M1 cell type has recently been implicated in the development of insulin resistance (13, 14, 36) . We therefore hypothesized that this function of C5aR could account for the observed phenotype of improved insulin sensitivity upon C5aR deficiency. First, we analyzed macrophage numbers in the WAT of HFD-fed C5aR-deficient and -proficient mice by IHC analysis for the macrophage marker F4/80 (Fig. 5) To further analyze changes in AT inflammation caused by C5aR deficiency, we determined the inflammatory profile of WAT by flow cytometry and quantitative PCR. The immune cell subpopulations in the SVF from sWAT and gWAT of C5aR-sufficient and -deficient mice fed an HFD were analyzed by flow cytometry. Although C5aR-sufficient and -deficient mice did not differ in the numbers of sWAT and gWAT total leukocytes (as assessed by staining for CD45) (Fig. 6A) http://www.jimmunol.org/ matory and are implicated in AT remodeling and dysfunction (11, 37) . Of interest, the number of these macrophages was also reduced in the sWAT and gWAT of C5aR 2/2 mice, compared with the respective tissues of C5aR-sufficient mice (Fig. 6F) . In contrast, CD8 + and CD4 + T cells in the sWAT and gWAT were unaltered owing to C5aR deficiency (Fig. 6G, 6H) . No significant differences in macrophages and total leukocytes between C5aR-deficient and -sufficient mice were observed upon ND feeding, as assessed by flow cytometry (data not shown). Together, these data indicate a reduction of M1-like macrophages in the obese AT, owing to C5aR deficiency.
Furthermore, by quantitative PCR analysis, we found that the expression of anti-inflammatory IL-10 was higher in the obese gWAT, but not in the obese sWAT, of C5aR-deficient mice, compared with WT mice (Supplemental Fig. 4A ; sWAT data not shown). In contrast, the proinflammatory cytokines IL-6 and TNF were not significantly lower owing to C5aR deficiency (Supplemental Fig. 4B ). No differences in the cytokine milieu of the liver caused by C5aR deficiency were observed (Supplemental Fig. 3C) .
The seeming discrepancy between increased AT weight, adipocyte size (Fig. 2) , and mildly improved insulin sensitivity associated with impaired AT inflammation caused by C5aR deficiency in obese male mice prompted us to analyze WAT fibrosis, which is linked to AT inflammation and indicates AT dysfunction. WAT fibrosis occurs by remodeling of the extracellular matrix in the dysfunctional obese AT and is mediated by macrophages (11, 38) . This process restricts expansion of adipocytes, limiting their size and capacity for triglyceride storage (11, 38) . In other words, we hypothesized that increased adipocyte size in the less inflamed and more insulin-sensitive C5aR-deficient AT could partially be linked to reduced WAT fibrosis. By Masson's trichrome staining, which is specific for collagen deposition, we found that gWAT of obese C5aR 2/2 mice displayed a striking reduction of fibrotic areas, compared with the gWAT of C5aR-sufficient mice (Supplemental Fig. 4C ). The reduced WAT fibrosis could be linked to the decreased amount of "intermediate" polarized, proinflammatory F4/80 + CD11c + CD206 + macrophages (Fig. 6F ) in the gWAT of C5aR-deficient mice, as this cell type is often detected in CLSs of fibrotic visceral tissue and is thought to trigger remodeling of dysfunctional WAT (11, 37, 39) .
C5aR deficiency does not affect pancreas morphology or b cell mass
Moreover, we tested whether changes in pancreatic islet morphology and function could contribute to the improvement in glucose tolerance of obese C5aR-deficient mice. To this end, we have analyzed islet morphology by insulin staining of the pancreas of WT and C5aR 2/2 male mice on DIO and by measuring b cell mass. No differences in islet morphology or b cell mass resulting from C5aR deficiency were detectable (Supplemental Fig. 3D, 3E ). Taken together, our data suggest that the mild improvement in glucose tolerance and insulin resistance in C5aR deficiency is due to reduced inflammation and fibrosis in the gWAT, which results in improved gWAT insulin resistance, whereas no alterations in the liver or the pancreatic islets were observed in C5aR deficiency.
Discussion
An intimate link between obesity and WAT inflammation has been identified recently (1, 3, 13, 14, 40, 41) . The inflamed microenvironment of the obese WAT triggers the accumulation of leukocytes, especially macrophages, in the WAT (1, 3, 13, 14, (40) (41) (42) . Macrophages accumulate mainly in the visceral WAT, which is in keeping with the higher contribution of the visceral than of the subcutaneous fat to insulin resistance (40, 41) . In this study, we identified a previously unknown component of the intriguing crosstalk between macrophage accumulation and activation in the WAT and insulin resistance development. Specifically, we found that the C5a-C5aR axis contributes to macrophage accumulation in the WAT, to macrophage polarization to M1 cells, as well as to WAT fibrosis and thereby to WAT insulin resistance.
Whereas female C5aR-deficient mice did not show any difference in weight gain or adipocyte size upon ND or HFD feeding, male C5aR-deficient mice were prone to increased adipocyte size of the gWAT upon feeding of an ND and an HFD, as well as to increased weight gain under ND conditions , compared with C5aR-sufficient mice. Intriguingly, we observed a mild, yet significant, improvement in systemic insulin sensitivity in both sexes in C5aR deficiency. Whereas we found no influence of C5aR deficiency on the insulin sensitivity of the liver or on pancreatic b cell mass in the course of DIO, we found improved insulin sensitivity of the obese gWAT in C5aR deficiency, associated with decreased accumula- tion of macrophages in the WAT-and their reduced polarization to proinflammatory M1 cells-as well as with decreased AT fibrosis. Moreover, IL-10 in the obese gWAT was higher owing to C5aR deficiency; consistent with our finding, IL-10 was recently shown to protect mice from DIO and glucose intolerance (43) . The levels of C5aR were increased in the obese AT. Moreover, we found that C5a was activated in the obese AT, as opposed to lean AT; C5a in the obese AT localized mainly in the macrophage-rich CLSs of the obese AT. Together, these data suggest that C5a accumulated in the obese AT localizes in the proximity of AT macrophages and signals via C5aR on the latter, mediating further accumulation of macrophages, their polarization to the M1 proinflammatory phenotype, and AT inflammation and fibrosis-and thereby contributing to gWAT insulin resistance. Our data on the role of C5aR in AT inflammation provide evidence for a novel function of the complement system in obesity. Previous studies mostly referred to the complement component ASP, a degradation product of C3a, as a regulator of adipogenesis. ASP can regulate fatty acid uptake and storage in adipocytes (15, 44, 45) . In addition, disruption of the second C5a receptor (46), C5L2, in mice resulted in development of diet-induced insulin resistance, associated with altered ectopic fat deposition and a proinflammatory phenotype (47) . These apparently distinct functions of the two C5a receptors-C5aR, as analyzed in the current study, and C5L2, as shown previously (15, 17, 19, 20, 44, (46) (47) (48) in obesity, AT inflammation, and development of insulin resistance are intriguing and merit further investigation.
In fact, the increased adipocyte size in C5aR 2/2 male mice, as observed in this study, could be due to increased C5a-mediated signaling via C5L2, as well as the different expression and function of C5aR and C5L2 in distinct cell populations in the AT microenvironment. C5L2 deficiency has been associated with reduced adipocyte size, higher glucose uptake, and worsened insulin resistance (47, 49) . Thus, enhanced activation of C5L2 by C5a in the absence of C5aR could lead to increased adipocyte size and weight gain in C5aR-deficient mice under ND conditions. We think that a future study should be performed that compares mice having a double deficiency of C5aR and C5L2 with mice having a single deficiency of either receptor, as well as with WT mice, to further address in detail the crosstalk between both C5a receptors in the AT. A common denominator may exist for the reciprocal regulation of macrophage numbers and adipocyte size in the gWAT attributable to C5aR deficiency in males. Although increased adipocyte size positively correlates with the frequency of adipocyte death (50) leading to increased leukocyte recruitment in the AT (1, 3, 13, 14, (40) (41) (42) , one function of macrophages in the obese WAT is the remodeling of the extracellular matrix around hypertrophic adipocytes (11, 38) , rendering the tissue fibrotic, which could in turn limit adipocyte growth and the capacity for triglyceride storage. Consistently, more fibrosis is found in obese, macrophage-rich visceral WAT than in macrophage-poorer subcutaneous fat (11) . In line with this finding, we detected fewer fibrotic areas in the gWAT from C5aR-deficient mice. This finding is likely linked not only to the decreased accumulation of the proinflammatory M1 macrophages but also to the reduced numbers of the profibrotic "intermediate" M1/M2-type F4/80 + CD11c + CD206 + macrophages in the WAT, owing to C5aR deficiency. Intriguingly, reduced fibrosis as a result of C5aR inhibition has been previously described for various tissues, including the heart, kidney, and lung (51) (52) (53) . Besides its known role in leukocyte recruitment and tissue inflammation, C5a could also directly interact with tissue fibroblasts and alter their ability for tissue remodeling (51) . In the case of WAT, it is conceivable that the reduced gWAT fibrosis of C5aR-deficient mice could potentially explain the phenotype of increased adipocyte size. Of interest, a similar phenotype (improved peripheral insulin sensitivity despite increased adipocyte size) was observed in GM-CSF-deficient mice, which had decreased macrophage numbers in the WAT as well (54) . The potential reciprocal correlation between macrophage numbers and adipocyte size in obese AT needs to be addressed in future investigations.
Intriguingly, C5aR deficiency had no influence on islet morphology or b cell mass. Increased glucose levels and pancreatic amyloid deposition in obesity and diabetes may result in b cell death, a process that is regulated by inflammatory cells (55) (56) (57) . Amyloid deposits can promote complement activation, thereby enhancing islet inflammation (48, 58) . In our studies we could not detect any effect of C5aR deficiency on pancreatic islets in the course of DIO. Thus, the liver and the pancreas remained unaffected in obese C5aR-deficient mice, and only obese gWAT insulin sensitivity was improved in C5aR deficiency, accompanied by decreased total and M1 macrophages in the WAT and reduced AT fibrosis. These findings are quite in keeping with the relatively mild metabolic phenotype in obesity attributable to C5aR deficiency, as altering only one of the many components contributing to insulin resistance, namely, WAT macrophages, could hardly influence whole-body insulin resistance more than the phenotype observed in this study. Our present findings also underline that insulin resistance can only be partially attributed to WAT macrophage activation and polarization. Consistent with our findings, in a very recent article, a C5aR antagonist inhibited DIO-induced metabolic dysfunction in rats (59) , whereas another very recent study (60) did not find alterations in GTT and ITT owing to C5aR deficiency in mice, which is likely explained by the different high fat diets used in the study by Roy et al. (60) and our study. Taken together, our data suggest that the complement C5a-C5aR axis contributes to macrophage accumulation and polarization to M1 cells in the obese WAT-and thereby to AT inflammation and fibrosis and the development of AT insulin resistance. Our findings may also have potential therapeutic implications: C5aR might represent a novel target to control progression of insulin resistance in obese individuals, a hypothesis worth testing in future studies.
